External R&D Engine for Venture Studios

The modern biotech landscape is increasingly defined by "virtual" or venture-backed startups that lack their own wet-lab infrastructure. ALTP is positioned as a strategic "Integrated Drug Discovery Engine" rather than a transactional service provider, serving as the outsourced R&D arm for venture studios and portfolio companies.

As an External R&D (ERAD) partner, we manage end-to-end programs from target validation through to IND-enabling studies. Our model allows venture studios (such as Curie.Bio and Pureos) to scale execution across multiple portfolio companies simultaneously, leveraging our specialized surgical suites and integrated DMPK platform as a shared resource. We don't just sell studies; we provide the infrastructure and scientific partnership required to turn early concepts into clinical-ready assets.